- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 14, 2025 | 6.2M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $8.66M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $11.98M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $21.65M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $23.47M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $76.99M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $79.75M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $58.55M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $61.61M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $156.13M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $162.34M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 5.85M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 5.85M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $0 |
| Capex | Q2 2025 · Dec 31, 2023 | $1.71M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $4.84M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $85.46M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $88.82M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $88.77M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.52 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.64 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.52 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.64 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $3.9M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $7.58M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$3.07M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$3.77M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$3.51M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$4.06M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $387K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $3.52M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $24.82M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $55.65M |